Skip to content

Author

I. Filin

We have 2 of 12 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Jul 2026

Current Aspects of Cellular Immunotherapy for Melanoma

An analysis of clinical trial data shows that combination approaches that combine cellular therapy with immune checkpoint inhibitors or standard treatments are the most effective, highlighting the need for further research in personalized immunotherapy for melanoma.

Chulpan B. Kharisova, A. Gorodilova, Y. Mayasin et al. · 0 citations
#gene editing Review Open access Aug 2026

Genetically Modified MSCs for Targeted Regeneration: Balancing Efficacy, Biosafety, and GMP Standardization

Development of safe-harbor integration and B2M/CIITA-based hypoimmunogenic designs as strategies to reduce engineering-related batch variability and HLA-dependent donor variability support a transition from empirical optimized MSC preparations toward molecularly defined cellular medicines with predefined genotype, expr...

Kristina V. Kitaeva, I. Filin, A. Rizvanov et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.